PMID: 7939135Jan 1, 1994Paper

Expression of the components and regulatory proteins of the classical pathway of complement in normal and diseased synovium

Rheumatology International
P GulatiK Whaley

Abstract

We studied the synthesis of the classical pathway complement components in synovial membrane. Ribonucleic acid was extracted from the synovial membranes of patients with rheumatoid arthritis (RA) or osteoarthritis (OA), as well as from normal synovial membrane. Northern blot and dot blot analysis showed that the mRNAs for all classical pathway complement components (C1qA chain, C1qB chain, C1qC chain, C1r, C1s, C4 and C2) and the fluid-phase regulatory components (C1-inhibitor, C4-bp and factor I) were present in all three types of synovial membrane. Thus, all the components of the classical pathway were expressed in normal and diseased synovium. In an attempt to determine which components were synthesised by each cell type, monocytes (mononuclear phagocytes), human umbilical vein endothelial cells (HUVEC), synovial membrane fibroblasts (from normal, OA and RA synovial membrane) and peripheral blood lymphocytes were cultured in vitro and secretion rates of individual components were measured and total cellular RNA was analysed by Northern blotting. Monocytes secreted C1q, C1r, C1s, C4, C2, C1-inhibitor and C4-bp but not factor I. Fibroblasts secreted C1r, C1s, C2, C3, C1-inhibitor and factor I but not C1q, C4 or C4-bp. HUVEC se...Continue Reading

References

Mar 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·J M DayerD R Robinson
Jun 1, 1990·The Biochemical Journal·D F LappinK Whaley
Mar 1, 1990·Arthritis and Rheumatism·W P Arend, J M Dayer
Sep 12, 1989·Nucleic Acids Research·V Barbu, F Dautry
Jun 1, 1988·The Journal of Pathology·N A AthanasouJ O McGee
Nov 1, 1988·Arthritis and Rheumatism·Y Katz, R C Strunk
Jun 6, 1974·The New England Journal of Medicine·S Ruddy, H R Colten
Feb 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·D R Bentley, R R Porter
Jan 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·M C Carroll, R R Porter

❮ Previous
Next ❯

Citations

May 9, 2002·Biochimica Et Biophysica Acta·Michael G Walker
Nov 7, 2008·Genes and Immunity·M J H Coenen, P K Gregersen
Apr 10, 2007·Journal of Autoimmunity·Ilaria CavazzanaMeroni Pier Luigi
Feb 26, 2005·Clinical and Experimental Immunology·S Chapuy-RegaudG Serre
Nov 28, 2008·Arthritis and Rheumatism·J M MilnerA D Rowan
Feb 5, 2010·Arthritis and Rheumatism·Robert M HoekJörg Hamann
Feb 24, 2018·British Journal of Pharmacology·David J WilkinsonAndrew D Rowan
Jun 20, 1998·Circulation Research·K YasojimaP L McGeer
Feb 1, 2007·Journal of Fluorescence·Milada IkanovicCarrie J Andrews
Feb 9, 2018·Nature Reviews. Rheumatology·Katerina OikonomopoulouVinod Chandran
Sep 16, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Camilla Melin FürstAnna M Blom
Jun 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Max Albert HietalaMarcela Pekna
Oct 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christopher J Del NagroRobert C Rickert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.